On Invalid Date, Opko Health (NASDAQ: OPK) reported Q2 2024 earnings per share (EPS) of -$0.01, up 66.67% year over year. Total Opko Health earnings for the quarter were -$10.31 million. In the same quarter last year, Opko Health's earnings per share (EPS) was -$0.03.
As of Q3 2024, Opko Health's earnings has grown year over year. Opko Health's earnings in the past year totalled -$243.10 million.
What is OPK's earnings date?
Opko Health's earnings date is Invalid Date. Add OPK to your watchlist to be reminded of OPK's next earnings announcement.
What was OPK's revenue last quarter?
On Invalid Date, Opko Health (NASDAQ: OPK) reported Q2 2024 revenue of $182.19 million up 31.36% year over year. In the same quarter last year, Opko Health's revenue was $265.42 million.
What was OPK's revenue growth in the past year?
As of Q3 2024, Opko Health's revenue has grown -17.48% year over year. This is 17.39 percentage points lower than the US Diagnostics & Research industry revenue growth rate of -0.09%. Opko Health's revenue in the past year totalled $716.37 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.